Agentic AI Is Outperforming GenAI in Asia s Hospitals, and the Shift Is Just Beginning

The Rise of Agentic AI: Why Asia's Hospitals Are Moving Beyond Generative Models

The conversation around artificial intelligence in healthcare has shifted. For years, generative AI^✦ captured headlines and budgets across Asia Pacific hospitals. But a quieter revolution is underway: machines that don't just generate suggestions, but make decisions, execute tasks, and improve clinical outcomes autonomously. Agentic^✦ AI is outperforming its more celebrated cousin, and Asia's leading healthcare providers are taking notice.

IDC's 2026 FutureScape report tells the story clearly: 75% of Asia Pacific care providers say agentic AI outperforms generative AI in productivity. This isn't a marginal difference. It reflects a fundamental shift in how hospitals approach automation; one that promises to reshape clinical workflows across the region over the coming years.

Seventy-five per cent of Asia Pacific care providers report that agentic AI delivers greater productivity gains than generative AI alone.

What Sets Agentic AI Apart

Generative AI creates content; agentic AI acts. The distinction matters profoundly in healthcare, where context and accountability are non-negotiable.

While generative AI excels at summarising text, writing reports, or drafting responses, agentic AI autonomously plans workflows, makes clinical decisions, and executes complex multi-step tasks. In a perioperative setting, this difference translates to hundreds of saved hours; in diagnostic imaging, it means faster turnaround on critical results; in administrative work, it frees clinicians to focus on patients.

Singapore General Hospital exemplifies this shift. Its "Peach" system (Perioperative AI Chatbot) handles pre-operative assessments independently, saving 660 doctor hours annually. Rather than generating a summary for a human to review, Peach executes the assessment workflow itself: flagging risks and gathering data without constant supervision. Singapore's commitment to AI governance has enabled rapid deployment of such systems.

Similarly, Qure.ai has processed 10.7 million scans across 90+ countries and 3,100+ sites. The company's agentic approach delivers diagnostic results in under 20 seconds with a 99% negative predictive value and a 40% reduction in reporting turnaround time. This is autonomous intelligence operating at scale^✦.

The Budget Shift Is Already Underway

The financial data mirrors the performance gains. Agentic AI's share of generative AI budgets is rising sharply, from 18% in 2025 to 29% in 2026. This acceleration reflects a pragmatic recognition among hospital leaders: agentic systems deliver measurable ROI where it matters most.

Coupled with APAC healthcare's overall generative AI spending doubling by 2026, the region is investing heavily in both modalities. Yet the emphasis is shifting. Deloitte's latest survey identifies agentic AI as health leaders' top priority after regulatory compliance. Eighty-five per cent of executives plan agentic investments; 61% are already building agentic solutions for enterprise AI agents in clinical workflows.

However, infrastructure gaps remain significant. While 89% of organisations have generalised GenAI infrastructure, only 51% have built agentic capabilities. This mismatch creates both risk and opportunity for early movers willing to invest in proper governance frameworks, as highlighted by recent findings on agentic AI deployment challenges.

Real-World Impact Across APAC

The evidence from leading institutions tells a compelling story.

South Korea has achieved near-universal adoption of AI tools among its medical workforce, with nearly half of registered doctors using AI systems for medical image interpretation. This adoption didn't happen by accident; it reflects years of regulatory clarity and investment in both training and infrastructure.

In China, multimodal AI systems achieve 98% accuracy detecting biliary atresia, a rare paediatric condition requiring early intervention. These systems combine imaging analysis with clinical context to identify disease patterns humans might miss. IDC predicts that by 2030, multimodal AI will predict 50% of chronic and rare diseases before symptoms emerge, fundamentally altering preventative care. Beyond healthcare, discussions of broader agentic AI implementations in consumer technology complement clinical innovations.

Sentara Health in the United States (a bellwether for global healthcare AI adoption) has automated nursing documentation through agentic systems, saving thousands of hours annually. While not APAC-based, its success foreshadows what Asia's larger health systems will achieve as they deploy similar solutions. The growing interest in Samsung AI companions and other everyday AI tools signals broader market readiness for agentic technologies.

By 2030, IDC forecasts that 33% of top-tier hospitals in APAC will deploy AI agents for real-time clinical decision support operating above 80% accuracy thresholds. This represents a fundamental reorganisation of the clinical environment: not towards replacing doctors, but towards augmenting their decision-making with machines that learn, adapt, and execute reliably.

The Hybrid Care Future

Eighty per cent of patients may rely on hybrid care models by 2027, blending human clinicians, agentic AI systems, and patient-facing generative interfaces. This shift offers significant benefits: earlier detection, faster treatment, reduced administrative burden on clinicians, and improved consistency of care.

Yet governance challenges loom. Boomi's partnership with Financial Times Longitude found that just 2% of organisations have fully accountable AI agents. Nearly 80% lack visibility or control over their agentic systems, a sobering reality given healthcare's regulatory demands.

Just two per cent of organisations have fully accountable AI agents, and nearly 80% lack visibility or control over their autonomous systems.

The consequence: despite agentic AI's performance advantages, its deployment requires investment in governance areas most organisations haven't prioritised. This challenge is particularly acute in emerging markets, where Malaysia's transition from guidelines to formal AI legislation reflects broader regional moves toward accountability frameworks.

1. Explainability^✦ frameworks: understanding why an agentic system made a specific decision
2. Audit trails: maintaining complete logs of autonomous actions for regulatory and clinical review
3. Human oversight protocols: designing effective handoffs between autonomous and human decision-making
4. Testing and validation: ensuring agentic systems perform reliably across diverse patient populations and rare conditions
5. Data governance: ensuring training data is representative and bias^✦ is minimised
6. Change management: preparing clinical teams for fundamentally new workflows

Frequently Asked Questions

How does agentic AI differ from generative AI in healthcare settings?

Generative AI produces content: summaries, draft reports, or suggestions that clinicians review and act upon. Agentic AI autonomously executes workflows. It plans, decides, and acts without waiting for human approval at each step. In perioperative contexts, this means pre-operative assessments complete without intervention. In radiology, diagnostic results deliver in seconds rather than hours. The performance difference reflects this fundamental distinction.

What is stopping wider adoption of agentic AI across APAC hospitals?

Three primary barriers: infrastructure (only 51% have agentic systems built), governance (80% lack visibility into autonomous decisions), and talent (few organisations have teams experienced in deploying accountable AI). Regulatory clarity also remains inconsistent across the region, though this is improving in countries like Singapore and South Korea.

Will agentic AI replace clinicians?

No. IDC forecasts 80% of patients using hybrid care by 2027, with human clinicians working alongside agentic systems. The evidence suggests agentic AI will eliminate routine administrative tasks and accelerate decision-making, freeing clinicians for higher-value work: complex diagnosis, patient communication, and care coordination.

Which APAC countries are leading agentic AI adoption in healthcare?

Singapore, South Korea, and China lead. Singapore General Hospital's Peach system and Singapore's regulatory framework^✦ position the nation ahead. South Korea's near-universal adoption of medical AI tools among doctors reflects years of investment. China's multimodal AI advances in disease detection demonstrate significant progress, though governance frameworks are still developing.

What should hospital leaders prioritise when deploying agentic AI?

Start with high-impact, low-complexity workflows: administrative tasks, routine image interpretation, pre-operative assessments. Build governance frameworks simultaneously: explainability, audit trails, and human oversight protocols. Invest in team training and change management. The organisations winning with agentic AI aren't those moving fastest, but those building accountability first.

Drop your take in the comments below.